# Valacyclovir Augmentation for Cognitive and Functional Remediation in Schizophrenia

> **NCT01794897** · PHASE4 · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 134 (actual)

## Conditions studied

- Herpes Simplex
- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** Experimental: Valacyclovir treatment
- **DRUG:** Placebo comparator

## Key facts

- **NCT ID:** NCT01794897
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2016-10-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01794897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01794897, "Valacyclovir Augmentation for Cognitive and Functional Remediation in Schizophrenia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01794897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*